Published in Int Arch Allergy Appl Immunol on January 01, 1968
M proteins of group A streptococci. Bacteriol Rev (1974) 3.15
A cross-reaction between Str. pyogenes and human fibroblasts, endothelial cells and astrocytes. Immunology (1971) 1.82
Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol (2010) 1.11
Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A (1986) 5.12
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol (2001) 2.27
Invasive group A streptococcal infections. N Engl J Med (1996) 2.16
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Prediction of readmissions after CABG using detailed follow-up data: the Israeli CABG Study (ISCAB) Med Care (1999) 1.62
Immunoprecipitating factors of vaccinia virus. Virology (1965) 1.60
NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A (2001) 1.58
Thermophoresis of DNA determined by microfluidic fluorescence. Eur Phys J E Soft Matter (2004) 1.54
Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study. Scand J Infect Dis (1996) 1.46
Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis (1976) 1.44
Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis (1992) 1.43
Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis (1994) 1.42
Expression of streptococcal plasmid-determined resistance to erythromycin and lincomycin in Escherichia coli. Mol Gen Genet (1981) 1.40
Penetration of antibiotics into the normal and diseased maxillary sinus mucosa. Scand J Infect Dis Suppl (1978) 1.39
Influence of combinations of oral bacteria on periapical tissues of monkeys. Scand J Dent Res (1982) 1.35
Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun (1994) 1.34
Case of apparent reinfection with rubella. Lancet (1970) 1.31
Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis (1996) 1.31
Effects of benzylpenicillin on Streptococcus pyogenes during the postantibiotic phase in vitro. J Antimicrob Chemother (1989) 1.27
Streptococcal anti-group A precipitins in sera from patients with rheumatic arthritis and acute glomerulonephritis. Int Arch Allergy Appl Immunol (1970) 1.27
Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis (1998) 1.26
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC). Ann Oncol (2005) 1.23
Thermodiffusion of charged colloids: single-particle diffusion. Langmuir (2007) 1.22
Density profile of group B streptococci, type III, and its possible relation to enhanced virulence. J Clin Microbiol (1987) 1.21
Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis (1993) 1.21
Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun (1994) 1.21
Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17
Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb Pathog (1988) 1.16
No correlation of focal contacts and close adhesion by comparing GFP-vinculin and fluorescence interference of Dil. Eur Biophys J (2001) 1.14
Absence of HLA association or linkage for variations in sensitivity to the odor of androstenone. Immunogenetics (1982) 1.14
[15N,1H]/[13C,1H]-TROSY for simultaneous detection of backbone 15N-1H, aromatic 13C-1H and side-chain 15N-1H2 correlations in large proteins. J Biomol NMR (2000) 1.13
Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. Scand J Infect Dis (1995) 1.12
Sequence-specific NMR assignment of proteins by global fragment mapping with the program MAPPER. J Biomol NMR (2000) 1.12
Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl (1983) 1.10
Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis (1986) 1.09
Long-term antibiotic treatment of chronic bacterial prostatitis. Effect on bacterial flora. Br J Urol (1989) 1.09
In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol (1999) 1.08
Some clinical, immunological and bacteriological observations in a case of pyogenic arthritis due to bacteroides fragilis. Scand J Infect Dis (1975) 1.08
Can decreased phagocytosis and killing of autologous gram-positive bacteria explain the finding of gram-positive bacteria in "non-bacterial prostatitis"? Acta Pathol Microbiol Immunol Scand B (1987) 1.07
Molecular cloning in streptococci: physical mapping of the vehicle plasmid pSM10 and demonstration of intergroup DNA transfer. Mol Gen Genet (1981) 1.06
An antigenic relationship between kidney and certain Escherichia coli strains. Int Arch Allergy Appl Immunol (1971) 1.06
Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl (1978) 1.05
The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care (1997) 1.04
Reevaluation of experiments intended to demonstrate immunological cross-reactions between mammalian tissues and streptococci. Prog Allergy (1979) 1.04
A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate. Anal Biochem (1989) 1.03
Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood (1998) 1.02
Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 1.02
In-vitro antibacterial activity of SQ 26,776. J Antimicrob Chemother (1981) 1.01
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Ann Oncol (2005) 1.01
The role of household contacts in the transmission of group A streptococci. Scand J Infect Dis (1997) 1.00
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol (2011) 1.00
The prevalence of potential pathogenic bacteria in nasopharyngeal samples from healthy children and adults. Scand J Prim Health Care (1998) 1.00
Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo. J Antimicrob Chemother (1990) 1.00
Purification of immunolobulin G Fc-reactive factor from Streptococcus azgazardah. Acta Pathol Microbiol Scand C (1976) 1.00
Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol (2007) 0.99
Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc (1981) 0.99
Effects of C-reactive protein on lymphocyte functions. III. Inhibition of antigen-induced lymphocyte stimulation and lymphokine production. Cell Immunol (1977) 0.99
Novel coagglutination method for serotyping group B streptococci. J Clin Microbiol (1992) 0.99
Hearing smiles and frowns in normal and whisper registers. J Acoust Soc Am (1994) 0.98
Exciton transfer dynamics and quantumness of energy transfer in the Fenna-Matthews-Olson complex. Phys Rev E Stat Nonlin Soft Matter Phys (2011) 0.98
Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis (1988) 0.98
Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J Infect Dis (1999) 0.97
Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep). Cancer (1980) 0.97
Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child (2008) 0.97
Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131. Infect Immun (2000) 0.97
The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics (2000) 0.97
Factors that enhance the potency of streptococcal group-specific antisera. J Infect Dis (1971) 0.97
Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scand J Infect Dis (1981) 0.97
Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun (1998) 0.97
Demonstration and characterization of buoyant-density subpopulations of group B Streptococcus type III. J Infect Dis (1990) 0.96
Accidental head trauma and retinal hemorrhage. Neurosurgery (1993) 0.96
Three-dimensional structure topology of the calreticulin P-domain based on NMR assignment. FEBS Lett (2001) 0.96
An in vivo model for evaluation of the postantibiotic effect. Scand J Infect Dis (1988) 0.96
Influenza immunization of children with neoplastic diseases. Cancer (1980) 0.95
Nonlinear voltage dependence of the light-driven proton pump current of bacteriorhodopsin. Biophys J (1988) 0.94
Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med (1998) 0.93
Osseous response to implanted natural bone mineral and synthetic hydroxylapatite ceramic in the repair of experimental skull bone defects. J Oral Maxillofac Surg (1992) 0.93
The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol (2010) 0.92
Small-fragment restriction endonuclease analysis in epidemiological mapping of group A streptococci. J Med Microbiol (1994) 0.92
Does excessive occlusal load affect osseointegration? An experimental study in the dog. Clin Oral Implants Res (2004) 0.91
Biliary lipid composition in normalipidemic and prebeta hyperlipoproteinemic gallstone patients. Influence of sucrose feeding of the patients on the biliary lipid composition. Scand J Gastroenterol (1973) 0.91
Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase, and modified nucleosides as biological markers in malignant lymphomas. Recent Results Cancer Res (1983) 0.91
Precipitinogens in beta-hemolytic streptococci and some related human kidney antigens. Acta Pathol Microbiol Scand (1967) 0.91
Impairment of phagocytosis by moderate hyperoxia (40 to 60 per cent oxygen) in lung macrophages. Lab Invest (1980) 0.91
A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal Toxicol (2008) 0.90
Antisocial patients: a comparison of those with and those without childhood conduct disorder. Ann Clin Psychiatry (1998) 0.90
Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (1999) 0.90
Interference of alpha-hemolytic streptococci isolated from tonsillar surface on beta-hemolytic streptococci (Streptococcus pyogenes)--a methodological study. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.90
Chronic maxillary sinusitis. Differential diagnosis and genesis. Acta Otolaryngol (1982) 0.89
Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otorhinolaryngol (1993) 0.89
Single-dose pharmacokinetics of dicloxacillin in healthy subjects of young and old age. Scand J Infect Dis (1986) 0.89